Arcadia Biosciences (FRA:17D) COGS-to-Revenue : 0.65 (As of Mar. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Arcadia Biosciences COGS-to-Revenue?

Arcadia Biosciences's Cost of Goods Sold for the three months ended in Mar. 2024 was €0.76 Mil. Its Revenue for the three months ended in Mar. 2024 was €1.16 Mil.

Arcadia Biosciences's COGS to Revenue for the three months ended in Mar. 2024 was 0.65.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Arcadia Biosciences's Gross Margin % for the three months ended in Mar. 2024 was 34.63%.

Arcadia Biosciences COGS-to-Revenue Historical Data

The historical data trend for Arcadia Biosciences's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcadia Biosciences COGS-to-Revenue Chart

Arcadia Biosciences Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

COGS-to-Revenue

Get a 7-Day Free Trial

0.76

0.65

1.28

0.82

0.62

Arcadia Biosciences Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
COGS-to-Revenue	Get a 7-Day Free Trial															0.56	0.71	0.69	0.57	0.65

Arcadia Biosciences COGS-to-Revenue Calculation

Arcadia Biosciences's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	3.026	/	4.888
	=	0.62

Arcadia Biosciences's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	0.755	/	1.155
	=	0.65

Arcadia Biosciences (FRA:17D) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Arcadia Biosciences's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	0.755 / 1.155
	=	34.63 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Arcadia Biosciences COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Arcadia Biosciences's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Arcadia Biosciences (FRA:17D) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Arcadia Biosciences Inc (FRA:17D) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

RKDA:USA

Address

5950 Sherry Lane, Suite 215, Dallas, TX, USA, 75225

Website

https://www.arcadiabio.com

Arcadia Biosciences Inc is a producer and marketer of innovative, plant-based food and beverage products. It is engaged in science-based approaches to developing high-value crop improvements primarily in wheat, soy, and hemp, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health, and wellness products, and their viability for industrial applications. The company's consumer brands in the food, beverage, and body care categories include GoodWheat high-fiber pasta, Zola coconut water, ProVault topical pain relief, and SoulSpring bath and body care.

Arcadia Biosciences (FRA:17D) Headlines

No Headlines